The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADVANCED DRAIN SYS INC DEL COM 00790R104 671 7,448 SH   SOLE   7,448 0 0
CLOVER HEALTH INVESTMENTS CO COM CL A 18914F103 451 210,639 SH   SOLE   210,639 0 0
DAY ONE BIOPHARMACEUTICALS I COM 23954D109 593 33,125 SH   SOLE   33,125 0 0
DYNE THERAPEUTICS INC COM 26818M108 240 34,887 SH   SOLE   34,887 0 0
ISHARES TR RUS 2000 VAL ETF 464287630 57,183 420,000 SH   SOLE   420,000 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107 288 34,100 SH   SOLE   34,100 0 0
SELECT SECTOR SPDR TR ENERGY 81369Y506 60,302 843,269 SH   SOLE   843,269 0 0
VANGUARD INTL EQUITY INDEX F TT WRLD ST ETF 922042742 2,674 31,329 SH   SOLE   31,329 0 0